09.09.13
The Global Organization for EPA and DHA Omega-3 (GOED), Salt Lake City, UT, has challenged a new study published in the Journal of the National Cancer Institute that linked men with high blood concentrations of omega 3 fatty acids with an increased risk of prostate cancer.
“While any recommendation for supplementation should consider any associated risks, we believe the authors’ conclusion is irresponsible and blatantly ignores the totality of the scientific evidence that has been collected over multiple decades regarding the health benefits of marine omega 3 fatty acids.”
GOED also noted the study was not specifically designed to look at the relationship between omega 3 fatty acid intake and prostate cancer. In addition, the organization suggested that if the report’s findings were correct, prostate cancer would be rampant in any country with high seafood consumption (e.g., Scandinavia and Japan) and conversely, low level consumption should be protective, which is clearly not the case.
“While any recommendation for supplementation should consider any associated risks, we believe the authors’ conclusion is irresponsible and blatantly ignores the totality of the scientific evidence that has been collected over multiple decades regarding the health benefits of marine omega 3 fatty acids.”
GOED also noted the study was not specifically designed to look at the relationship between omega 3 fatty acid intake and prostate cancer. In addition, the organization suggested that if the report’s findings were correct, prostate cancer would be rampant in any country with high seafood consumption (e.g., Scandinavia and Japan) and conversely, low level consumption should be protective, which is clearly not the case.
